Cargando…
Repression of transcription by the glucocorticoid receptor: A parsimonious model for the genomics era
Glucocorticoids are potent anti-inflammatory drugs that are used to treat an extraordinary range of human disease, including COVID-19, underscoring the ongoing importance of understanding their molecular mechanisms. Early studies of GR signaling led to broad acceptance of models in which glucocortic...
Autores principales: | Gerber, Anthony N., Newton, Robert, Sasse, Sarah K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141881/ https://www.ncbi.nlm.nih.gov/pubmed/33891947 http://dx.doi.org/10.1016/j.jbc.2021.100687 |
Ejemplares similares
-
Ushering in the era of tRNA medicines
por: Anastassiadis, Theonie, et al.
Publicado: (2023) -
Nascent transcript analysis of glucocorticoid crosstalk with TNF defines primary and cooperative inflammatory repression
por: Sasse, Sarah K., et al.
Publicado: (2019) -
Still rocking in the structural era: A molecular overview of the small multidrug resistance (SMR) transporter family
por: Burata, Olive E., et al.
Publicado: (2022) -
Genomic determinants implicated in the glucocorticoid-mediated induction of KLF9 in pulmonary epithelial cells
por: Mostafa, Mahmoud M., et al.
Publicado: (2020) -
Sphingosine-1-phosphate and its receptors in vascular endothelial and lymphatic barrier function
por: Weigel, Cynthia, et al.
Publicado: (2023)